Jayne B. Hart Insider Trading $MYGN MYRIAD GENETICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jayne B. Hart.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jayne B. Hart. Jayne B. Hart is Chief People Officer in MYRIAD GENETICS INC ($MYGN) and Executive VP Human Resources in MYRIAD GENETICS INC ($MYGN).
Jayne B. Hart in MYRIAD GENETICS INC
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Jayne B. Hart: Chief People Officer, Executive VP Human Resources
Holdings: 108,128 shares
Current Value: $1,665,171
Latest Transaction: Mar 30 2021
$MYGN Market Capitalization: $1.13B
$MYGN Previous Close: $15.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jayne B. Hart in MYRIAD GENETICS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Option Exercise | M | 24.89 | 21,966 | 546,734 | 0 | |
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Option Exercise | M | 19.47 | 28,000 | 545,160 | 0 | |
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Option Exercise | M | 24.89 | 8,034 | 199,966 | 0 | |
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Sell | S | 30.00 | 8,034 | 241,020 | 80,128 | 88.2 K to 80.1 K (-9.11 %) |
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Buy | M | 24.89 | 8,034 | 199,966 | 88,162 | 80.1 K to 88.2 K (+10.03 %) |
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Sell | S | 30.00 | 21,966 | 658,980 | 80,128 | 102.1 K to 80.1 K (-21.52 %) |
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Buy | M | 24.89 | 21,966 | 546,734 | 102,094 | 80.1 K to 102.1 K (+27.41 %) |
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Sell | S | 30.00 | 28,000 | 840,000 | 80,128 | 108.1 K to 80.1 K (-25.90 %) |
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Buy | M | 19.47 | 28,000 | 545,160 | 108,128 | 80.1 K to 108.1 K (+34.94 %) |
| Mar 26 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Grant | A | 0.00 | 13,326 | 0 | 80,128 | 66.8 K to 80.1 K (+19.95 %) |
| Oct 01 2020 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | D | 13.04 | 2,218 | 28,923 | 48,949 | 51.2 K to 48.9 K (-4.33 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | D | 12.44 | 2,218 | 27,592 | 51,167 | 53.4 K to 51.2 K (-4.15 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | D | 12.44 | 1,664 | 20,700 | 53,385 | 55 K to 53.4 K (-3.02 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | D | 12.44 | 2,218 | 27,592 | 55,049 | 57.3 K to 55 K (-3.87 %) |
| Sep 18 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Grant | A | 0.00 | 25,000 | 0 | 26,193 | 1.2 K to 26.2 K (+2,095.56 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | M | 27.07 | 17,500 | 473,725 | 51,907 | |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | M | 24.89 | 21,966 | 546,734 | 21,966 | |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | M | 23.98 | 3,500 | 83,930 | 7,000 | |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | M | 19.47 | 28,000 | 545,160 | 28,000 | |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | M | 24.89 | 8,034 | 199,966 | 8,034 | |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | S | 40.90 | 8,034 | 328,566 | 930 | 9 K to 930 (-89.63 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Buy | M | 24.89 | 8,034 | 199,966 | 8,964 | 930 to 9 K (+863.87 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | S | 40.90 | 21,966 | 898,344 | 930 | 22.9 K to 930 (-95.94 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Buy | M | 24.89 | 21,966 | 546,734 | 22,896 | 930 to 22.9 K (+2,361.94 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | S | 40.90 | 28,000 | 1,145,116 | 930 | 28.9 K to 930 (-96.79 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Buy | M | 19.47 | 28,000 | 545,160 | 28,930 | 930 to 28.9 K (+3,010.75 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | S | 40.90 | 3,500 | 143,140 | 930 | 4.4 K to 930 (-79.01 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Buy | M | 23.98 | 3,500 | 83,930 | 4,430 | 930 to 4.4 K (+376.34 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | S | 40.90 | 17,500 | 715,698 | 930 | 18.4 K to 930 (-94.95 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Buy | M | 27.07 | 17,500 | 473,725 | 18,430 | 930 to 18.4 K (+1,881.72 %) |
| Sep 19 2013 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | A | 26.49 | 73,225 | 1,939,730 | 73,225 | |
| Sep 19 2013 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | A | 26.49 | 3,775 | 100,000 | 3,775 | |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | A | 27.07 | 69,407 | 1,878,847 | 69,407 | |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | A | 27.07 | 593 | 16,053 | 593 | |
| Mar 08 2012 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | A | 23.98 | 10,500 | 251,790 | 10,500 | |
| Mar 08 2012 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | A | 23.98 | 3,500 | 83,930 | 3,500 | |
| Sep 15 2011 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | A | 19.47 | 56,000 | 1,090,320 | 56,000 | |
| May 26 2011 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | A | 24.89 | 43,932 | 1,093,467 | 43,932 | |
| May 26 2011 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | A | 24.89 | 16,068 | 399,933 | 16,068 | |
| May 04 2011 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | A | 21.34 | 31,256 | 667,003 | 31,256 | |
| May 04 2011 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | A | 21.34 | 18,744 | 399,997 | 18,744 |
Page: 1